Vanguard Group Inc Cytek Biosciences, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CTKB
# of Institutions
135Shares Held
73.9MCall Options Held
200Put Options Held
100-
Black Rock Inc. New York, NY17.1MShares$88.8 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD11.4MShares$59.2 Million1.3% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$34.6 Million0.96% of portfolio
-
State Street Corp Boston, MA3.97MShares$20.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.58MShares$13.4 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $700M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...